Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. (Q47715661)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

autosomal dominant polycystic kidney disease

0 references

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

autosomal dominant polycystic kidney

1 reference

based on heuristic

inferred from title

object named as

Antonio Pisani

6

0 references

Massimo Imbriaco

object named as

Massimo Imbriaco

8

0 references

object named as

Andrea Remuzzi

19

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

20

0 references

Piero Ruggenenti

21

object named as

Piero Ruggenenti

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

3

object named as

Annalisa Perna

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Antonio De Pascalis

object named as

Antonio De Pascalis

14

0 references

object named as

Anna Caroli

1

0 references

Norberto Perico

2

object named as

Norberto Perico

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

17

object named as

Nadia Rubis

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Silvia Prandini

18

object named as

Silvia Prandini

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

15

object named as

Flavio Gaspari

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Fabiola Carrara

16

object named as

Fabiola Carrara

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Erasmo Buongiorno

13

object named as

Erasmo Buongiorno

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Piergiorgio Messa

9

object named as

Piergiorgio Messa

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

11

object named as

Mauro Dugo

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Bianca Visciano

7

object named as

Bianca Visciano

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

author name string

Luca Antiga

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Paolo Brambilla

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Roberta Cerutti

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Luca Cancian

12

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

ALADIN study group

22

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

language of work or name

0 references

publication date

21 August 2013

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

382

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

9903

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

1485-1495

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Clinical practice. Autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin limits rise in glomerular filtration rate after a protein meal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of recombinant human growth hormone (rhGH) on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long term octreotide on gall stone formation and gall bladder function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus in patients with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin analog therapy for severe polycystic liver disease: results after 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961407-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(13)61407-5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23972263

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47715661&oldid=1744067998"